Arts and Sciences Alumni Academy: The Ozempic Challenge

GLP-1 drugs have been all over the news these days. Drugs like Ozempic, Wegovy and others are prescribed for management of type 2 diabetes and weight, and their results seem nothing short of miraculous. However, the side effects of such drugs often force the majority of users to stop using these medications, and their ability to manage medical conditions long-term remain unknown.

On Thursday, March 27, join Robert Doyle, the Jack and Laura H. Milton Professor and Dean’s Professor of Chemistry, to learn about the history of obesity treatments like Ozempic and their potential limitations. Professor Doyle will cover his lab’s work to advance anti-obesity drug development, and how his cutting-edge research focuses on the next generation of weight loss drugs which offer significant and consistent weight loss and glucose control but without common, negative side-effects.

Register now